Alpaca nanobodies effective against South African SARS-CoV-2 variant
Alpaca nanobodies effective against South African SARS-CoV-2 variant Researchers in South Africa and the UK have identified alpaca-derived nanoantibodies that potently neutralize variants of the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) – the agent that causes coronavirus disease 2019 (COVID-19). Notably, one of the nanoantibodies neutralized the South African variant of concern B.1.351 that has been shown to reduce the effectiveness of vaccines against the virus. “...
Source: news-medical.net